We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Juvenilis myasthenia gravis - új kezelési lehetõségek a láthatáron.
- Authors
Beáta, Rosdy
- Abstract
Juvenile Myasthenia gravis is a rare autoimmune disorder under the age of 18 years. There are no treatment guidelines for paediatric patients. Therapy is lying on adult International Consensus Guidance, and retrospective paediatric cohort studies. Symptomatic therapy with anticholinesterase agents helps the neuromuscular transmission. In generalised forms immunosuppressants must be applied as well, with known side effects. Thymectomy is an established treatment in adult acetylcholine receptor antibody positive Myasthenia Gravis, but existing data in paediatric patients are limited and entirely retrospective. Many new effective targeted treatments have been developed for adult patients. Some of them have been already studied under 18, some are investigated. To get familiar with them is important for paediatricians as well.
- Subjects
MYASTHENIA gravis; CHILD patients; CHOLINESTERASE inhibitors; RECEPTOR antibodies; NEUROMUSCULAR transmission
- Publication
Gyermekgyógyászat, 2024, Vol 75, Issue 4, p231
- ISSN
0017-5900
- Publication type
Article